{"transactions":[{"id":1954331,"issuer":{"id":8507,"kind":"organization","name":"BIOTRICITY INC."},"owners":[{"id":115573,"kind":"person","name":"Al-Siddiq Waqaas","position":1,"cik":"0001783199","reported_name":"Al-Siddiq Waqaas","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO and Chairman"}}],"security":"Option (right to purchase)","published_at":"2023-03-14T16:26:54.000Z","date":"2023-03-12","kind":"grant","acquired":true,"shares":1000000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Granted pursuant to the 2016 Equity Incentive Plan, with 250,000 of the Option vested January 27, 2023, and the remaining unvested Option of 20,833 will become vested and exercisable every month thereafter starting on February 27, 2023, until the Option is 100% vested."}],"balance_after":4899984,"derivative":{"exercise_price":0.81,"expiration_date":"2033-01-27","underlying":"Common Stock","underlying_shares":1000000},"source":{"system":"sec-edgar","filing":"0001493152-23-007604","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1783199/000149315223007604/ownership.xml","form_type":"4"}},{"id":1954330,"issuer":{"id":8507,"kind":"organization","name":"BIOTRICITY INC."},"owners":[{"id":115573,"kind":"person","name":"Al-Siddiq Waqaas","position":1,"cik":"0001783199","reported_name":"Al-Siddiq Waqaas","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO and Chairman"}}],"security":"Option (right to purchase)","published_at":"2023-03-14T16:26:54.000Z","date":"2023-03-12","kind":"grant","acquired":true,"shares":350000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Granted pursuant to the 2016 Equity Incentive Plan, with 175,000 of the Option vested January 27, 2023, and the remaining unvested Option of 175,000 will vest on January 27, 2024."}],"balance_after":3899984,"derivative":{"exercise_price":1.75,"expiration_date":"2033-01-27","underlying":"Common Stock","underlying_shares":350000},"source":{"system":"sec-edgar","filing":"0001493152-23-007604","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1783199/000149315223007604/ownership.xml","form_type":"4"}},{"id":1954329,"issuer":{"id":8507,"kind":"organization","name":"BIOTRICITY INC."},"owners":[{"id":115573,"kind":"person","name":"Al-Siddiq Waqaas","position":1,"cik":"0001783199","reported_name":"Al-Siddiq Waqaas","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO and Chairman"}}],"security":"Option (right to purchase)","published_at":"2023-03-14T16:26:54.000Z","date":"2023-03-12","kind":"grant","acquired":true,"shares":350000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Granted pursuant to the 2016 Equity Incentive Plan, with 175,000 of the Option vested January 27, 2023, and the remaining unvested Option of 175,000 will vest on January 27, 2024."}],"balance_after":3549984,"derivative":{"exercise_price":1.25,"expiration_date":"2033-01-27","underlying":"Common Stock","underlying_shares":350000},"source":{"system":"sec-edgar","filing":"0001493152-23-007604","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1783199/000149315223007604/ownership.xml","form_type":"4"}},{"id":3124608,"issuer":{"id":8507,"kind":"organization","name":"BIOTRICITY INC."},"owners":[{"id":115573,"kind":"person","name":"Al-Siddiq Waqaas","position":1,"cik":"0001783199","reported_name":"Al-Siddiq Waqaas","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CEO and President"}}],"security":"Option (right to purchase)","published_at":"2020-06-03T16:34:44.000Z","date":"2020-04-07","kind":"grant","acquired":true,"shares":1400000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest quarterly over four years."}],"balance_after":1400000,"derivative":{"exercise_price":1.06,"expiration_date":"2025-04-07","underlying":"Common Stock","underlying_shares":1400000},"source":{"system":"sec-edgar","filing":"0001493152-20-010471","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1783199/000149315220010471/ownership.xml","form_type":"4/A","original_submission_date":"2020-04-09"}},{"id":3179086,"issuer":{"id":8507,"kind":"organization","name":"BIOTRICITY INC."},"owners":[{"id":115573,"kind":"person","name":"Al-Siddiq Waqaas","position":1,"cik":"0001783199","reported_name":"Al-Siddiq Waqaas","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CEO and President"}}],"security":"Option (right to purchase)","published_at":"2020-04-09T17:08:59.000Z","date":"2020-04-07","kind":"grant","acquired":true,"shares":1400000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest quarterly over four years."}],"balance_after":1400000,"derivative":{"exercise_price":0.98,"expiration_date":"2030-04-07","underlying":"Common Stock","underlying_shares":1400000},"source":{"system":"sec-edgar","filing":"0001493152-20-006129","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1783199/000149315220006129/ownership.xml","form_type":"4"}}]}